(Q43190925)

15 November 2017

0 references

Treating breast cancer before surgery (English)

1 reference

15 November 2017

Epstein R

1

1 reference

PMC publication ID

2352900

15 November 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

15 November 2017

1 reference

15 November 2017

313

1 reference

15 November 2017

7069

1 reference

15 November 2017

1345-1346

1 reference

I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.

15 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2352900

Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2352900

Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2352900

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2352900

Management of breast cancer in southeast England

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2352900

Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2352900

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2352900

Sixteen-week dose-intense chemotherapy in the adjuvant treatment of breast cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2352900

Specialist surgeons and survival in breast cancer. Large differences in survival are not explained

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2352900

c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer

15 August 2018

1 reference

12 December 2020

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer

1 reference

12 December 2020

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

1 reference

12 December 2020

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of f

1 reference

12 December 2020

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

1 reference

12 December 2020

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer

1 reference

12 December 2020

10.1136/BMJ.313.7069.1345

Identifiers

DOI

1 reference

15 November 2017

1 reference

PMC publication ID

2352900

15 November 2017

PubMed publication ID

8956687

1 reference

PMC publication ID

2352900